Loading interface...

Storvas Amf (5/10 mg) Tablet

Manufactured byRanbaxy Laboratories Ltd.
ContainsAmlodipine (5 mg) + Atorvastatin (10 mg)
Description
Storvas Amf (5/10 mg) Tablet is a combination of Amlodipine and Atorvastatin. It is used orally for the treatment of high blood pressure (hypertension) along with high cholesterol levels. Obese patients are at high risk of developing high blood pressure and also have an increased risk of heart attack and stroke. Storvas Amf (5/10 mg) Tablet works by relaxing your heart muscles and blood vessels that lowers the high blood pressure. It also blocks the formation of cholesterol in your body. Together, this medicine decreases high blood pressure and lowers cholesterol levels. Thus, it decreases the risk of heart attack and stroke. The common side effects of Storvas Amf (5/10 mg) Tablet use are headache, nausea, vomiting, stomach pain and feeling of warmth (in the face, neck and trunk). These side effects subside as your body starts adapting to this medicine. Consult your doctor if any side effects persist or worsen. Avoid taking this medicine if you were previously allergic to it. Storvas Amf (5/10 mg) Tablet can make you feel dizzy for the first few days. Do not drive or do anything that requires concentration until you know how Storvas Amf (5/10 mg) Tablet affects you. Your doctor may check your liver function before starting the treatment and regularly thereafter. Inform your doctor if you notice signs of liver problems such as stomach pain, unusually dark urine or yellowing of your skin or eyes. You can take Storvas Amf (5/10 mg) Tablet with or without food. Even if you feel well, do not stop this medicine on your own. If you stop taking it, your condition may get worse and would be hard to treat. Try not to skip the Storvas Amf (5/10 mg) Tablet dose and avoid an overdose of this medicine. To make sure Storvas Amf (5/10 mg) Tablet is safe for you, share your entire medical and medication history with your doctor. Inform your doctor if you are pregnant, planning a pregnancy or are breastfeeding.

Side effects

Major & minor side effects for Storvas Amf (5/10 mg) Tablet

  • Cough
  • Difficulty in swallowing
  • Diarrhoea
  • Increased liver enzyme levels
  • Joint pain
  • Muscle pain
  • Runny Nose
  • Difficulty in breathing
  • Insomnia
  • Swelling of ankles or feet
  • Dizziness
  • Increased heartbeat
  • Redness of face, neck, arms and chest
  • Acid or sour stomach
  • Stomach pain

Uses of Storvas Amf (5/10 mg) Tablet

What is it prescribed for?

  • Coexisting essential hypertension and hyperlipidemia
  • Angina pectoris
  • Prevention of cardiovascular diseases
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    Storvas Amf (5/10 mg) Tablet shows its action to decrease high blood pressure in 6 to 12 hours and to reduce cholesterols levels within 2 hours. However, this medicine may take few days to make you feel better.
  • How long do the effects of this medicine last?
    Storvas Amf (5/10 mg) Tablet may remain active up to 2-3 days in your body.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    Storvas Amf (5/10 mg) Tablet has no habit forming tendency.
  • Can this medicine be taken during pregnancy?
    Storvas Amf (5/10 mg) Tablet is not recommended for use during pregnancy as it can harm your foetus. Your doctor may prescribe a safer alternative based on your clinical condition.
  • Can this medicine be taken while breast-feeding?
    Storvas Amf (5/10 mg) Tablet is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Allergy

Avoid taking Storvas Amf (5/10 mg) Tablet if you are previously allergic to it. Seek an immediate medical attention if you notice any symptoms of allergic reactions such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulties, etc.

Liver Disease

Storvas Amf (5/10 mg) Tablet is converted into its active form by your liver. The presence of the liver disease may impair the conversion of this medicine into its active form thus leading to the accumulation of this medicine in your liver. This accumulation may worsen the liver condition. Hence, Storvas Amf (5/10 mg) Tablet is not recommended for use if you have active liver diseases.
Warnings for special population

Pregnancy

Storvas Amf (5/10 mg) Tablet is not recommended for use during pregnancy as it can harm your foetus. Your doctor may prescribe a safer alternative based on your clinical condition.

Breast-feeding

Storvas Amf (5/10 mg) Tablet is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General warnings

Cognitive impairment

Storvas Amf (5/10 mg) Tablet may cause forgetfulness, memory loss, confusion, etc. These side effects are reversible and usually disappear once the medicine is discontinued only after your doctor's advise.

Increased blood sugar levels

Storvas Amf (5/10 mg) Tablet may cause an increase in your blood sugar levels. It is recommended to closely monitor your blood sugar levels.

Alcohol consumption

Storvas Amf (5/10 mg) Tablet may cause liver and kidney related problems if you consume alcohol very frequently in large quantities while on treatment with this medicine.

Aortic stenosis

Aortic stenosis is the narrowing of the valves of the heart that regulate the blood flow between the heart chambers. Storvas Amf (5/10 mg) Tablet should be used with caution if you have aortic stenosis.

Pediatric use

Storvas Amf (5/10 mg) Tablet is not recommended for use in children since the safety and efficacy of use are not clinically established.

Driving and operating machines

Storvas Amf (5/10 mg) Tablet may cause dizziness or drowsiness. It is advised that you do not perform any activities that require high mental alertness. Avoid driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

If you forget to take a Storvas Amf (5/10 mg) Tablet dose, make sure that you remember to take your next dose on time. Do not take two doses together to make up for a forgotten dose.

Overdose

Never take Storvas Amf (5/10 mg) Tablet more than the prescribed dose. If you suspect that you might have taken an overdose of this medicine, go to the emergency department of your local hospital.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Itraconazole

Azithromycin

Atazanavir

Cyclosporine

Rifampicin

Gemfibrozil

Disease interactions

Diabetes

Caution should be exercised while taking Storvas Amf (5/10 mg) Tablet if you are diabetic (presence of high blood sugar levels). This medicine may alter your blood sugar levels. Your doctor may advise you to monitor the blood sugar levels frequently while you are on Storvas Amf (5/10 mg) Tablet.

Cardiogenic shock

Storvas Amf (5/10 mg) Tablet is not recommended for use in case of cardiogenic shock ( your heart suddenly stops pumping enough blood to the body) since it may worsen your heart condition.

Rhabdomyolysis

Caution should be exercised while taking Storvas Amf (5/10 mg) Tablet if you have rhabdomyolysis. Rhabdomyolysis is a condition in which damaged muscle fibres enter the bloodstream, leading to kidney failure.
Food interactions
Consumption of grapefruit juice is not recommended during treatment with Storvas Amf (5/10 mg) Tablet due to the increased risk of adverse effects such as dizziness, muscle pain, fever and chills, headache, swelling of hands and feet, vomiting, skin rash, etc.
Lab interactions
Information not available.
You can take Storvas Amf (5/10 mg) Tablet with or without food. Do not skip any doses of Storvas Amf (5/10 mg) Tablet and finish the full course of treatment even if you feel better. It can make you feel dizzy for the first few days. Do not drive or do anything that requires concentration until you know how Storvas Amf (5/10 mg) Tablet affects you. Your doctor may check your liver function before starting the treatment and regularly thereafter. Inform your doctor if you notice signs of liver problems such as stomach pains, unusually dark urine or yellowing of skin or eyes. Do not crush, break or chew the tablet.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Storvas Amf (5/10 mg) Tablet is a combination of Amlodipine and Atorvastatin. Amlodipine relaxes your heart muscles and the blood vessels. Atorvastatin reduces the level of cholesterol in your blood. Their combination is thus helpful in treating both hyperlipidemia and high blood pressure.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Antihyperlipidemic combinations, Miscellaneous antihypertensive combinations

Schedule

Schedule H

Medicines.org.uk. 2021. Amlodipine 10 mg tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 19 August 2021].

https://www.medicines.org.uk/emc/medicine/24889>

Medicines.org.uk. 2021. Atorvastatin 10 mg Tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 19 August 2021].

https://www.medicines.org.uk/emc/product/11199#INDICATIONS>

Drugs, H., 2021. Amlodipine: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 19 August 2021].

https://medlineplus.gov/druginfo/meds/a692044.html>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 19 August 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020702s056lbl.pdf>

Mri.cts-mrp.eu. 2021. [online] Available at: < [Accessed 19 August 2021].

https://mri.cts-mrp.eu/human/downloads/PT_H_0841_002_FinalSPC.pdf>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 19 Aug 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.